Literature DB >> 11213359

Effects by doxorubicin on the myocardium are mediated by oxygen free radicals.

M F Xu1, P L Tang, Z M Qian, M Ashraf.   

Abstract

We hypothesized that doxorubicin (DOX) induces cardiotoxicity of myocardium via oxygen radicals. The present study is aimed at examining the membrane alterations by oxygen radicals generated by DOX in adult rats and cultured neonatal myocytes. Our results showed that DOX 1) decreased beta-adrenoceptor (BAR) density in the cell membrane, 2) increased the membrane permeability of cultured neonatal rat myocytes and 3) altered the ultrastructure of myofibrils and subplasmalemmal actin networks. These effects were reproducible by exogenous hydrogen peroxide. The antioxidant melatonin (MLT) inhibited enzyme leakage and peroxidation in a concentration-dependent manner. It is concluded that DOX induces cardiotoxicity through lipid peroxidation and melatonin is an effective antioxidant against the reactive oxygen intermediates generated by DOX.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11213359     DOI: 10.1016/s0024-3205(00)00990-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  45 in total

1.  Anthracycline-induced cardiomyopathy: The search continues.

Authors:  Agnes S Kim; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2015-12-08       Impact factor: 5.952

2.  Close cardiac surveillance of patients treated with anthracyclines, also necessary after chemotherapy?

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2009-11-06       Impact factor: 2.357

3.  Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of doxorubicin cardiotoxicity.

Authors:  Salim Khiati; Ilaria Dalla Rosa; Carole Sourbier; Xuefei Ma; V Ashutosh Rao; Leonard M Neckers; Hongliang Zhang; Yves Pommier
Journal:  Clin Cancer Res       Date:  2014-04-08       Impact factor: 12.531

Review 4.  Minimising the long-term adverse effects of childhood leukaemia therapy.

Authors:  Claudia Langebrake; Dirk Reinhardt; Jörg Ritter
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  Doxorubicin-induced chronic dilated cardiomyopathy-the apoptosis hypothesis revisited.

Authors:  Cynthia Kankeu; Kylie Clarke; Egle Passante; Heinrich J Huber
Journal:  J Mol Med (Berl)       Date:  2016-12-08       Impact factor: 4.599

6.  Prevention of doxorubicin-induced cardiotoxicity by melatonin.

Authors:  Eser Oz; Deniz Erbaş; H Selçuk Sürücü; Ersel Düzgün
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

7.  Beneficial role of aminoguanidine on acute cardiomyopathy related to doxorubicin-treatment.

Authors:  Yilmaz Cigremis; Hakan Parlakpinar; Alaadin Polat; Cemil Colak; Feral Ozturk; Engin Sahna; Necip Ermis; Ahmet Acet
Journal:  Mol Cell Biochem       Date:  2006-04-13       Impact factor: 3.396

Review 8.  Hypolipidemic, antioxidant, and antiinflammatory activities of microalgae Spirulina.

Authors:  Ruitang Deng; Te-Jin Chow
Journal:  Cardiovasc Ther       Date:  2010-08       Impact factor: 3.023

9.  Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.

Authors:  Mary Putt; Virginia Shalkey Hahn; James L Januzzi; Heloisa Sawaya; Igal A Sebag; Juan Carlos Plana; Michael H Picard; Joseph R Carver; Elkan F Halpern; Irene Kuter; Jonathan Passeri; Victor Cohen; Jose Banchs; Randolph P Martin; Robert E Gerszten; Marielle Scherrer-Crosbie; Bonnie Ky
Journal:  Clin Chem       Date:  2015-07-27       Impact factor: 8.327

10.  Systolic versus diastolic cardiac function variables during epirubicin treatment for breast cancer.

Authors:  Jon M Appel; Benny V Jensen; Dorte L Nielsen; Marianne Ryberg; Bo Zerahn
Journal:  Int J Cardiovasc Imaging       Date:  2009-10-13       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.